PNC Financial Services Group
FULC icon

PNC Financial Services Group’s Fulcrum Therapeutics FULC Stock Holding History

PNC Financial Services Group’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282 Sell
77
-808
-91% -$4.92K ﹤0.01% 5070
2026
Q1 		$6.79K Sell
885
-557
-39% -$5.17K ﹤0.01% 4127
2025
Q4 		$16.3K Buy
1,442
+25
+2% +$254 ﹤0.01% 3759
2025
Q3 		$13K Sell
1,417
-32
-2% -$232 ﹤0.01% 3823
2025
Q2 		$9.97K Buy
1,449
+923
+175% +$4.94K ﹤0.01% 3872
2025
Q1 		$1.51K Buy
526
+521
+10,420% +$1.91K ﹤0.01% 4421
2024
Q4 		$24 Buy
+5
New +$18 ﹤0.01% 4755

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

PNC Financial Services Group's FULC Position: Q2 2026 in Review

PNC Financial Services Group reduced its Fulcrum Therapeutics (FULC) stake by 91% in Q2 2026, selling an estimated $4.92K and leaving 77 shares worth $282. The position accounts for ﹤0.01% of the portfolio, ranked #5070.

PNC Financial Services Group first reported a position in FULC in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.3K in Q4 2025. 43 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • PNC Financial Services Group held 77 shares of Fulcrum Therapeutics worth $282 as of Q2 2026.
  • PNC Financial Services Group sold 808 Fulcrum Therapeutics shares in Q2 2026, an estimated $4.92K.
  • Fulcrum Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5070 holding.
  • PNC Financial Services Group first reported a position in Fulcrum Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • PNC Financial Services Group's Fulcrum Therapeutics position peaked at $16.3K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.